Celgene quarterly profit rises 17.5 percent
April 27, 2017 at 07:35 AM EDT
April 27 (Reuters) - U.S. biotechnology company Celgene Corp reported a 17.5 percent jump in quarterly net income on Thursday, helped by demand for its flagship multiple myeloma drug Revlimid.